aroxybutynin   Click here for help

GtoPdb Ligand ID: 14589

Synonyms: (-)-oxybutynin | (r)-oxybutynin | (R)OXY [3]
Compound class: Synthetic organic
Comment: Aroxybutynin is the R-enantiomer of racemic oxybutynin. It is reported as the enantiomer that is predominantly responsible for the antimuscarinic effect of oxybutynin [3].
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 1
Rotatable bonds 8
Topological polar surface area 49.77
Molecular weight 357.49
XLogP 3.72
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCN(CC)CC#CCOC(=O)[C@](C1=CC=CC=C1)(C2CCCCC2)O
Isomeric SMILES CCN(CC)CC#CCOC(=O)[C@@](C1CCCCC1)(C2=CC=CC=C2)O
InChI InChI=1S/C22H31NO3/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3/t22-/m0/s1
InChI Key XIQVNETUBQGFHX-QFIPXVFZSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

No information available.
Summary of Clinical Use Click here for help
Aroxybutynin is being investigated in a fixed-dose combination with atomoxetine (a noradrenaline reuptake inhibitor), as a treatment that is intended to reduce upper airway collapse in patients with obstructive sleep apnoea [1,4,7]. The combination pill is known as AD109 (or Oxnimbi®) [2].
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT05811247 Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo) Phase 3 Interventional Apnimed
NCT05813275 Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study) Phase 3 Interventional Apnimed 6
NCT05071612 Parallel Arm Trial of AD109 and AD504 In Patients With OSA Phase 2 Interventional Apnimed 5